Suppr超能文献

生物信息学分析鉴定肺结核预后的新型生物标志物。

A bioinformatics analysis to identify novel biomarkers for prognosis of pulmonary tuberculosis.

机构信息

Department of Pulmonary and Critical Care Medicine, Haining People's Hospital, Jiaxing, 314400, China.

Department of Respiratory and Critical Care Medicine, Changhai Hospital, Naval Medical University (Second Military Medical University), No. 168 Changhai Road, Yangpu District, Shanghai, 200433, China.

出版信息

BMC Pulm Med. 2020 Oct 24;20(1):279. doi: 10.1186/s12890-020-01316-2.

Abstract

BACKGROUND

Due to the fact that pulmonary tuberculosis (PTB) is a highly infectious respiratory disease characterized by high herd susceptibility and hard to be treated, this study aimed to search novel effective biomarkers to improve the prognosis and treatment of PTB patients.

METHODS

Firstly, bioinformatics analysis was performed to identify PTB-related differentially expressed genes (DEGs) from GEO database, which were then subjected to GO annotation and KEGG pathway enrichment analysis to initially describe their functions. Afterwards, clustering analysis was conducted to identify PTB-related gene clusters and relevant PPI networks were established using the STRING database.

RESULTS

Based on the further differential and clustering analyses, 10 DEGs decreased during PTB development were identified and considered as candidate hub genes. Besides, we retrospectively analyzed some relevant studies and found that 7 genes (CCL20, PTGS2, ICAM1, TIMP1, MMP9, CXCL8 and IL6) presented an intimate correlation with PTB development and had the potential serving as biomarkers.

CONCLUSIONS

Overall, this study provides a theoretical basis for research on novel biomarkers of PTB, and helps to estimate PTB prognosis as well as probe into targeted molecular treatment.

摘要

背景

由于肺结核(PTB)是一种高度传染性的呼吸道疾病,具有高群体易感性和难以治疗的特点,本研究旨在寻找新的有效生物标志物,以改善 PTB 患者的预后和治疗。

方法

首先,从 GEO 数据库中进行生物信息学分析,以识别与 PTB 相关的差异表达基因(DEGs),然后进行 GO 注释和 KEGG 通路富集分析,初步描述其功能。然后,进行聚类分析以识别与 PTB 相关的基因簇,并使用 STRING 数据库建立相关的 PPI 网络。

结果

基于进一步的差异和聚类分析,确定了 10 个在 PTB 发展过程中减少的 DEG,并将其视为候选关键基因。此外,我们回顾性分析了一些相关研究,发现 7 个基因(CCL20、PTGS2、ICAM1、TIMP1、MMP9、CXCL8 和 IL6)与 PTB 发展密切相关,具有作为生物标志物的潜力。

结论

总的来说,本研究为研究 PTB 的新型生物标志物提供了理论基础,并有助于估计 PTB 的预后以及探索靶向分子治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9300/7585184/797ced1873e4/12890_2020_1316_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验